Global Bacteriophage Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Description

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.

According to our (Global Info Research) latest study, the global Bacteriophage Therapy market size was valued at USD 33 million in 2022 and is forecast to a readjusted size of USD 61 million by 2029 with a CAGR of 9.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.

This report is a detailed and comprehensive analysis for global Bacteriophage Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Bacteriophage Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Bacteriophage Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Bacteriophage Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Bacteriophage Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bacteriophage Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bacteriophage Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Armata Pharmaceuticals, Inc., Eliava Biopreparations Ltd., Pherecydes Pharma, Intralytix, Inc. and Phagelux Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Bacteriophage Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Oral
    Topical
    Parenteral

Market segment by Application
    Organ Transplantation
    Bacterial Infections
    Alcoholic Hepatitis
    Other

Market segment by players, this report covers
    Armata Pharmaceuticals, Inc.
    Eliava Biopreparations Ltd.
    Pherecydes Pharma
    Intralytix, Inc.
    Phagelux Inc.
    Nextbiotics
    InnoPhage, Ltd
    Locus Biosciences, Inc.
    TechnoPhage
    Eligo Bioscience SA
    Phagomed Biopharma GmbH.
    PhagePro, Inc.
    Adaptive Phage Therapeutics, Inc.
    EnBiotix, Inc.
    Intodeworld, Inc.
    BiomX Ltd.
    Phi Therapeutics
    Fixed-phage Ltd.
    Micreos BV
    ContraFect Corporation

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Bacteriophage Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Bacteriophage Therapy, with revenue, gross margin and global market share of Bacteriophage Therapy from 2018 to 2023.
Chapter 3, the Bacteriophage Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Bacteriophage Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Bacteriophage Therapy.
Chapter 13, to describe Bacteriophage Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Bacteriophage Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Bacteriophage Therapy by Type
        1.3.1 Overview: Global Bacteriophage Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Bacteriophage Therapy Consumption Value Market Share by Type in 2022
        1.3.3 Oral
        1.3.4 Topical
        1.3.5 Parenteral
    1.4 Global Bacteriophage Therapy Market by Application
        1.4.1 Overview: Global Bacteriophage Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Organ Transplantation
        1.4.3 Bacterial Infections
        1.4.4 Alcoholic Hepatitis
        1.4.5 Other
    1.5 Global Bacteriophage Therapy Market Size & Forecast
    1.6 Global Bacteriophage Therapy Market Size and Forecast by Region
        1.6.1 Global Bacteriophage Therapy Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Bacteriophage Therapy Market Size by Region, (2018-2029)
        1.6.3 North America Bacteriophage Therapy Market Size and Prospect (2018-2029)
        1.6.4 Europe Bacteriophage Therapy Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Bacteriophage Therapy Market Size and Prospect (2018-2029)
        1.6.6 South America Bacteriophage Therapy Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Bacteriophage Therapy Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Armata Pharmaceuticals, Inc.
        2.1.1 Armata Pharmaceuticals, Inc. Details
        2.1.2 Armata Pharmaceuticals, Inc. Major Business
        2.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product and Solutions
        2.1.4 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Armata Pharmaceuticals, Inc. Recent Developments and Future Plans
    2.2 Eliava Biopreparations Ltd.
        2.2.1 Eliava Biopreparations Ltd. Details
        2.2.2 Eliava Biopreparations Ltd. Major Business
        2.2.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Product and Solutions
        2.2.4 Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Eliava Biopreparations Ltd. Recent Developments and Future Plans
    2.3 Pherecydes Pharma
        2.3.1 Pherecydes Pharma Details
        2.3.2 Pherecydes Pharma Major Business
        2.3.3 Pherecydes Pharma Bacteriophage Therapy Product and Solutions
        2.3.4 Pherecydes Pharma Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Pherecydes Pharma Recent Developments and Future Plans
    2.4 Intralytix, Inc.
        2.4.1 Intralytix, Inc. Details
        2.4.2 Intralytix, Inc. Major Business
        2.4.3 Intralytix, Inc. Bacteriophage Therapy Product and Solutions
        2.4.4 Intralytix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Intralytix, Inc. Recent Developments and Future Plans
    2.5 Phagelux Inc.
        2.5.1 Phagelux Inc. Details
        2.5.2 Phagelux Inc. Major Business
        2.5.3 Phagelux Inc. Bacteriophage Therapy Product and Solutions
        2.5.4 Phagelux Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Phagelux Inc. Recent Developments and Future Plans
    2.6 Nextbiotics
        2.6.1 Nextbiotics Details
        2.6.2 Nextbiotics Major Business
        2.6.3 Nextbiotics Bacteriophage Therapy Product and Solutions
        2.6.4 Nextbiotics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Nextbiotics Recent Developments and Future Plans
    2.7 InnoPhage, Ltd
        2.7.1 InnoPhage, Ltd Details
        2.7.2 InnoPhage, Ltd Major Business
        2.7.3 InnoPhage, Ltd Bacteriophage Therapy Product and Solutions
        2.7.4 InnoPhage, Ltd Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 InnoPhage, Ltd Recent Developments and Future Plans
    2.8 Locus Biosciences, Inc.
        2.8.1 Locus Biosciences, Inc. Details
        2.8.2 Locus Biosciences, Inc. Major Business
        2.8.3 Locus Biosciences, Inc. Bacteriophage Therapy Product and Solutions
        2.8.4 Locus Biosciences, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Locus Biosciences, Inc. Recent Developments and Future Plans
    2.9 TechnoPhage
        2.9.1 TechnoPhage Details
        2.9.2 TechnoPhage Major Business
        2.9.3 TechnoPhage Bacteriophage Therapy Product and Solutions
        2.9.4 TechnoPhage Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 TechnoPhage Recent Developments and Future Plans
    2.10 Eligo Bioscience SA
        2.10.1 Eligo Bioscience SA Details
        2.10.2 Eligo Bioscience SA Major Business
        2.10.3 Eligo Bioscience SA Bacteriophage Therapy Product and Solutions
        2.10.4 Eligo Bioscience SA Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Eligo Bioscience SA Recent Developments and Future Plans
    2.11 Phagomed Biopharma GmbH.
        2.11.1 Phagomed Biopharma GmbH. Details
        2.11.2 Phagomed Biopharma GmbH. Major Business
        2.11.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Product and Solutions
        2.11.4 Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Phagomed Biopharma GmbH. Recent Developments and Future Plans
    2.12 PhagePro, Inc.
        2.12.1 PhagePro, Inc. Details
        2.12.2 PhagePro, Inc. Major Business
        2.12.3 PhagePro, Inc. Bacteriophage Therapy Product and Solutions
        2.12.4 PhagePro, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 PhagePro, Inc. Recent Developments and Future Plans
    2.13 Adaptive Phage Therapeutics, Inc.
        2.13.1 Adaptive Phage Therapeutics, Inc. Details
        2.13.2 Adaptive Phage Therapeutics, Inc. Major Business
        2.13.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product and Solutions
        2.13.4 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Adaptive Phage Therapeutics, Inc. Recent Developments and Future Plans
    2.14 EnBiotix, Inc.
        2.14.1 EnBiotix, Inc. Details
        2.14.2 EnBiotix, Inc. Major Business
        2.14.3 EnBiotix, Inc. Bacteriophage Therapy Product and Solutions
        2.14.4 EnBiotix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 EnBiotix, Inc. Recent Developments and Future Plans
    2.15 Intodeworld, Inc.
        2.15.1 Intodeworld, Inc. Details
        2.15.2 Intodeworld, Inc. Major Business
        2.15.3 Intodeworld, Inc. Bacteriophage Therapy Product and Solutions
        2.15.4 Intodeworld, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Intodeworld, Inc. Recent Developments and Future Plans
    2.16 BiomX Ltd.
        2.16.1 BiomX Ltd. Details
        2.16.2 BiomX Ltd. Major Business
        2.16.3 BiomX Ltd. Bacteriophage Therapy Product and Solutions
        2.16.4 BiomX Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 BiomX Ltd. Recent Developments and Future Plans
    2.17 Phi Therapeutics
        2.17.1 Phi Therapeutics Details
        2.17.2 Phi Therapeutics Major Business
        2.17.3 Phi Therapeutics Bacteriophage Therapy Product and Solutions
        2.17.4 Phi Therapeutics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 Phi Therapeutics Recent Developments and Future Plans
    2.18 Fixed-phage Ltd.
        2.18.1 Fixed-phage Ltd. Details
        2.18.2 Fixed-phage Ltd. Major Business
        2.18.3 Fixed-phage Ltd. Bacteriophage Therapy Product and Solutions
        2.18.4 Fixed-phage Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.18.5 Fixed-phage Ltd. Recent Developments and Future Plans
    2.19 Micreos BV
        2.19.1 Micreos BV Details
        2.19.2 Micreos BV Major Business
        2.19.3 Micreos BV Bacteriophage Therapy Product and Solutions
        2.19.4 Micreos BV Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.19.5 Micreos BV Recent Developments and Future Plans
    2.20 ContraFect Corporation
        2.20.1 ContraFect Corporation Details
        2.20.2 ContraFect Corporation Major Business
        2.20.3 ContraFect Corporation Bacteriophage Therapy Product and Solutions
        2.20.4 ContraFect Corporation Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.20.5 ContraFect Corporation Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Bacteriophage Therapy Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Bacteriophage Therapy by Company Revenue
        3.2.2 Top 3 Bacteriophage Therapy Players Market Share in 2022
        3.2.3 Top 6 Bacteriophage Therapy Players Market Share in 2022
    3.3 Bacteriophage Therapy Market: Overall Company Footprint Analysis
        3.3.1 Bacteriophage Therapy Market: Region Footprint
        3.3.2 Bacteriophage Therapy Market: Company Product Type Footprint
        3.3.3 Bacteriophage Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Bacteriophage Therapy Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Bacteriophage Therapy Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Bacteriophage Therapy Consumption Value Market Share by Application (2018-2023)
    5.2 Global Bacteriophage Therapy Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Bacteriophage Therapy Consumption Value by Type (2018-2029)
    6.2 North America Bacteriophage Therapy Consumption Value by Application (2018-2029)
    6.3 North America Bacteriophage Therapy Market Size by Country
        6.3.1 North America Bacteriophage Therapy Consumption Value by Country (2018-2029)
        6.3.2 United States Bacteriophage Therapy Market Size and Forecast (2018-2029)
        6.3.3 Canada Bacteriophage Therapy Market Size and Forecast (2018-2029)
        6.3.4 Mexico Bacteriophage Therapy Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Bacteriophage Therapy Consumption Value by Type (2018-2029)
    7.2 Europe Bacteriophage Therapy Consumption Value by Application (2018-2029)
    7.3 Europe Bacteriophage Therapy Market Size by Country
        7.3.1 Europe Bacteriophage Therapy Consumption Value by Country (2018-2029)
        7.3.2 Germany Bacteriophage Therapy Market Size and Forecast (2018-2029)
        7.3.3 France Bacteriophage Therapy Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Bacteriophage Therapy Market Size and Forecast (2018-2029)
        7.3.5 Russia Bacteriophage Therapy Market Size and Forecast (2018-2029)
        7.3.6 Italy Bacteriophage Therapy Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Bacteriophage Therapy Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Bacteriophage Therapy Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Bacteriophage Therapy Market Size by Region
        8.3.1 Asia-Pacific Bacteriophage Therapy Consumption Value by Region (2018-2029)
        8.3.2 China Bacteriophage Therapy Market Size and Forecast (2018-2029)
        8.3.3 Japan Bacteriophage Therapy Market Size and Forecast (2018-2029)
        8.3.4 South Korea Bacteriophage Therapy Market Size and Forecast (2018-2029)
        8.3.5 India Bacteriophage Therapy Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Bacteriophage Therapy Market Size and Forecast (2018-2029)
        8.3.7 Australia Bacteriophage Therapy Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Bacteriophage Therapy Consumption Value by Type (2018-2029)
    9.2 South America Bacteriophage Therapy Consumption Value by Application (2018-2029)
    9.3 South America Bacteriophage Therapy Market Size by Country
        9.3.1 South America Bacteriophage Therapy Consumption Value by Country (2018-2029)
        9.3.2 Brazil Bacteriophage Therapy Market Size and Forecast (2018-2029)
        9.3.3 Argentina Bacteriophage Therapy Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Bacteriophage Therapy Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Bacteriophage Therapy Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Bacteriophage Therapy Market Size by Country
        10.3.1 Middle East & Africa Bacteriophage Therapy Consumption Value by Country (2018-2029)
        10.3.2 Turkey Bacteriophage Therapy Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Bacteriophage Therapy Market Size and Forecast (2018-2029)
        10.3.4 UAE Bacteriophage Therapy Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Bacteriophage Therapy Market Drivers
    11.2 Bacteriophage Therapy Market Restraints
    11.3 Bacteriophage Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Bacteriophage Therapy Industry Chain
    12.2 Bacteriophage Therapy Upstream Analysis
    12.3 Bacteriophage Therapy Midstream Analysis
    12.4 Bacteriophage Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Bacteriophage Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Bacteriophage Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Bacteriophage Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Bacteriophage Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Armata Pharmaceuticals, Inc. Company Information, Head Office, and Major Competitors
    Table 6. Armata Pharmaceuticals, Inc. Major Business
    Table 7. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product and Solutions
    Table 8. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Armata Pharmaceuticals, Inc. Recent Developments and Future Plans
    Table 10. Eliava Biopreparations Ltd. Company Information, Head Office, and Major Competitors
    Table 11. Eliava Biopreparations Ltd. Major Business
    Table 12. Eliava Biopreparations Ltd. Bacteriophage Therapy Product and Solutions
    Table 13. Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Eliava Biopreparations Ltd. Recent Developments and Future Plans
    Table 15. Pherecydes Pharma Company Information, Head Office, and Major Competitors
    Table 16. Pherecydes Pharma Major Business
    Table 17. Pherecydes Pharma Bacteriophage Therapy Product and Solutions
    Table 18. Pherecydes Pharma Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Pherecydes Pharma Recent Developments and Future Plans
    Table 20. Intralytix, Inc. Company Information, Head Office, and Major Competitors
    Table 21. Intralytix, Inc. Major Business
    Table 22. Intralytix, Inc. Bacteriophage Therapy Product and Solutions
    Table 23. Intralytix, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Intralytix, Inc. Recent Developments and Future Plans
    Table 25. Phagelux Inc. Company Information, Head Office, and Major Competitors
    Table 26. Phagelux Inc. Major Business
    Table 27. Phagelux Inc. Bacteriophage Therapy Product and Solutions
    Table 28. Phagelux Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Phagelux Inc. Recent Developments and Future Plans
    Table 30. Nextbiotics Company Information, Head Office, and Major Competitors
    Table 31. Nextbiotics Major Business
    Table 32. Nextbiotics Bacteriophage Therapy Product and Solutions
    Table 33. Nextbiotics Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Nextbiotics Recent Developments and Future Plans
    Table 35. InnoPhage, Ltd Company Information, Head Office, and Major Competitors
    Table 36. InnoPhage, Ltd Major Business
    Table 37. InnoPhage, Ltd Bacteriophage Therapy Product and Solutions
    Table 38. InnoPhage, Ltd Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. InnoPhage, Ltd Recent Developments and Future Plans
    Table 40. Locus Biosciences, Inc. Company Information, Head Office, and Major Competitors
    Table 41. Locus Biosciences, Inc. Major Business
    Table 42. Locus Biosciences, Inc. Bacteriophage Therapy Product and Solutions
    Table 43. Locus Biosciences, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Locus Biosciences, Inc. Recent Developments and Future Plans
    Table 45. TechnoPhage Company Information, Head Office, and Major Competitors
    Table 46. TechnoPhage Major Business
    Table 47. TechnoPhage Bacteriophage Therapy Product and Solutions
    Table 48. TechnoPhage Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. TechnoPhage Recent Developments and Future Plans
    Table 50. Eligo Bioscience SA Company Information, Head Office, and Major Competitors
    Table 51. Eligo Bioscience SA Major Business
    Table 52. Eligo Bioscience SA Bacteriophage Therapy Product and Solutions
    Table 53. Eligo Bioscience SA Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Eligo Bioscience SA Recent Developments and Future Plans
    Table 55. Phagomed Biopharma GmbH. Company Information, Head Office, and Major Competitors
    Table 56. Phagomed Biopharma GmbH. Major Business
    Table 57. Phagomed Biopharma GmbH. Bacteriophage Therapy Product and Solutions
    Table 58. Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Phagomed Biopharma GmbH. Recent Developments and Future Plans
    Table 60. PhagePro, Inc. Company Information, Head Office, and Major Competitors
    Table 61. PhagePro, Inc. Major Business
    Table 62. PhagePro, Inc. Bacteriophage Therapy Product and Solutions
    Table 63. PhagePro, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. PhagePro, Inc. Recent Developments and Future Plans
    Table 65. Adaptive Phage Therapeutics, Inc. Company Information, Head Office, and Major Competitors
    Table 66. Adaptive Phage Therapeutics, Inc. Major Business
    Table 67. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product and Solutions
    Table 68. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Adaptive Phage Therapeutics, Inc. Recent Developments and Future Plans
    Table 70. EnBiotix, Inc. Company Information, Head Office, and Major Competitors
    Table 71. EnBiotix, Inc. Major Business
    Table 72. EnBiotix, Inc. Bacteriophage Therapy Product and Solutions
    Table 73. EnBiotix, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. EnBiotix, Inc. Recent Developments and Future Plans
    Table 75. Intodeworld, Inc. Company Information, Head Office, and Major Competitors
    Table 76. Intodeworld, Inc. Major Business
    Table 77. Intodeworld, Inc. Bacteriophage Therapy Product and Solutions
    Table 78. Intodeworld, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. Intodeworld, Inc. Recent Developments and Future Plans
    Table 80. BiomX Ltd. Company Information, Head Office, and Major Competitors
    Table 81. BiomX Ltd. Major Business
    Table 82. BiomX Ltd. Bacteriophage Therapy Product and Solutions
    Table 83. BiomX Ltd. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 84. BiomX Ltd. Recent Developments and Future Plans
    Table 85. Phi Therapeutics Company Information, Head Office, and Major Competitors
    Table 86. Phi Therapeutics Major Business
    Table 87. Phi Therapeutics Bacteriophage Therapy Product and Solutions
    Table 88. Phi Therapeutics Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Phi Therapeutics Recent Developments and Future Plans
    Table 90. Fixed-phage Ltd. Company Information, Head Office, and Major Competitors
    Table 91. Fixed-phage Ltd. Major Business
    Table 92. Fixed-phage Ltd. Bacteriophage Therapy Product and Solutions
    Table 93. Fixed-phage Ltd. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 94. Fixed-phage Ltd. Recent Developments and Future Plans
    Table 95. Micreos BV Company Information, Head Office, and Major Competitors
    Table 96. Micreos BV Major Business
    Table 97. Micreos BV Bacteriophage Therapy Product and Solutions
    Table 98. Micreos BV Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 99. Micreos BV Recent Developments and Future Plans
    Table 100. ContraFect Corporation Company Information, Head Office, and Major Competitors
    Table 101. ContraFect Corporation Major Business
    Table 102. ContraFect Corporation Bacteriophage Therapy Product and Solutions
    Table 103. ContraFect Corporation Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 104. ContraFect Corporation Recent Developments and Future Plans
    Table 105. Global Bacteriophage Therapy Revenue (USD Million) by Players (2018-2023)
    Table 106. Global Bacteriophage Therapy Revenue Share by Players (2018-2023)
    Table 107. Breakdown of Bacteriophage Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 108. Market Position of Players in Bacteriophage Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 109. Head Office of Key Bacteriophage Therapy Players
    Table 110. Bacteriophage Therapy Market: Company Product Type Footprint
    Table 111. Bacteriophage Therapy Market: Company Product Application Footprint
    Table 112. Bacteriophage Therapy New Market Entrants and Barriers to Market Entry
    Table 113. Bacteriophage Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 114. Global Bacteriophage Therapy Consumption Value (USD Million) by Type (2018-2023)
    Table 115. Global Bacteriophage Therapy Consumption Value Share by Type (2018-2023)
    Table 116. Global Bacteriophage Therapy Consumption Value Forecast by Type (2024-2029)
    Table 117. Global Bacteriophage Therapy Consumption Value by Application (2018-2023)
    Table 118. Global Bacteriophage Therapy Consumption Value Forecast by Application (2024-2029)
    Table 119. North America Bacteriophage Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 120. North America Bacteriophage Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 121. North America Bacteriophage Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 122. North America Bacteriophage Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 123. North America Bacteriophage Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 124. North America Bacteriophage Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 125. Europe Bacteriophage Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 126. Europe Bacteriophage Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 127. Europe Bacteriophage Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 128. Europe Bacteriophage Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 129. Europe Bacteriophage Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 130. Europe Bacteriophage Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 131. Asia-Pacific Bacteriophage Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 132. Asia-Pacific Bacteriophage Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 133. Asia-Pacific Bacteriophage Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 134. Asia-Pacific Bacteriophage Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 135. Asia-Pacific Bacteriophage Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 136. Asia-Pacific Bacteriophage Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 137. South America Bacteriophage Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 138. South America Bacteriophage Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 139. South America Bacteriophage Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 140. South America Bacteriophage Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 141. South America Bacteriophage Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 142. South America Bacteriophage Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 143. Middle East & Africa Bacteriophage Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 144. Middle East & Africa Bacteriophage Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 145. Middle East & Africa Bacteriophage Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 146. Middle East & Africa Bacteriophage Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 147. Middle East & Africa Bacteriophage Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 148. Middle East & Africa Bacteriophage Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 149. Bacteriophage Therapy Raw Material
    Table 150. Key Suppliers of Bacteriophage Therapy Raw Materials
List of Figures
    Figure 1. Bacteriophage Therapy Picture
    Figure 2. Global Bacteriophage Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Bacteriophage Therapy Consumption Value Market Share by Type in 2022
    Figure 4. Oral
    Figure 5. Topical
    Figure 6. Parenteral
    Figure 7. Global Bacteriophage Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 8. Bacteriophage Therapy Consumption Value Market Share by Application in 2022
    Figure 9. Organ Transplantation Picture
    Figure 10. Bacterial Infections Picture
    Figure 11. Alcoholic Hepatitis Picture
    Figure 12. Other Picture
    Figure 13. Global Bacteriophage Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Bacteriophage Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Market Bacteriophage Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 16. Global Bacteriophage Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 17. Global Bacteriophage Therapy Consumption Value Market Share by Region in 2022
    Figure 18. North America Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 20. Asia-Pacific Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 21. South America Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 22. Middle East and Africa Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 23. Global Bacteriophage Therapy Revenue Share by Players in 2022
    Figure 24. Bacteriophage Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 25. Global Top 3 Players Bacteriophage Therapy Market Share in 2022
    Figure 26. Global Top 6 Players Bacteriophage Therapy Market Share in 2022
    Figure 27. Global Bacteriophage Therapy Consumption Value Share by Type (2018-2023)
    Figure 28. Global Bacteriophage Therapy Market Share Forecast by Type (2024-2029)
    Figure 29. Global Bacteriophage Therapy Consumption Value Share by Application (2018-2023)
    Figure 30. Global Bacteriophage Therapy Market Share Forecast by Application (2024-2029)
    Figure 31. North America Bacteriophage Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 32. North America Bacteriophage Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 33. North America Bacteriophage Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 34. United States Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 35. Canada Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 36. Mexico Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 37. Europe Bacteriophage Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 38. Europe Bacteriophage Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 39. Europe Bacteriophage Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 40. Germany Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 41. France Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 42. United Kingdom Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 43. Russia Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 44. Italy Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 45. Asia-Pacific Bacteriophage Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 46. Asia-Pacific Bacteriophage Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 47. Asia-Pacific Bacteriophage Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 48. China Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 49. Japan Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 50. South Korea Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 51. India Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 52. Southeast Asia Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 53. Australia Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 54. South America Bacteriophage Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 55. South America Bacteriophage Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 56. South America Bacteriophage Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 57. Brazil Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 58. Argentina Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 59. Middle East and Africa Bacteriophage Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 60. Middle East and Africa Bacteriophage Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 61. Middle East and Africa Bacteriophage Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 62. Turkey Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 63. Saudi Arabia Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 64. UAE Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 65. Bacteriophage Therapy Market Drivers
    Figure 66. Bacteriophage Therapy Market Restraints
    Figure 67. Bacteriophage Therapy Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of Bacteriophage Therapy in 2022
    Figure 70. Manufacturing Process Analysis of Bacteriophage Therapy
    Figure 71. Bacteriophage Therapy Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source

Companies Mentioned

Armata Pharmaceuticals, Inc.
Eliava Biopreparations Ltd.
Pherecydes Pharma
Intralytix, Inc.
Phagelux Inc.
Nextbiotics
InnoPhage, Ltd
Locus Biosciences, Inc.
TechnoPhage
Eligo Bioscience SA
Phagomed Biopharma GmbH.
PhagePro, Inc.
Adaptive Phage Therapeutics, Inc.
EnBiotix, Inc.
Intodeworld, Inc.
BiomX Ltd.
Phi Therapeutics
Fixed-phage Ltd.
Micreos BV
ContraFect Corporation